SR ONE Capital Management, LLC, 10% Owner at Zenas BioPharma, Inc. (ZBIO), bought 126,315 shares at $19.00 ($2.4M) on 2025-10-09, disclosed to the SEC on 2025-10-14.
Open-market purchase of $2.4M ZBIO by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.00 | 63,157 | $1.2M | 50.0% |
| 2 | $19.00 | 63,158 | $1.2M | 50.0% |
| Total | $19.00 avg | 126,315 | $2.4M | 100% |
| Filing → |
| ODTX | SELL | 2026-05-11 | $32K | — | Filing → |
| AVLN | BUY | 2026-05-01 | $10.0M | — | Filing → |
| ZBIO | BUY | 2024-09-16 | $30.5M | — | Filing → |